These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 36712848)
1. Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature. Zhou J; Chen D; Zhang S; Wang C; Zhang L Front Genet; 2022; 13():1039983. PubMed ID: 36712848 [TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
3. Role of cuproptosis-related gene in lung adenocarcinoma. Liu Y; Lin W; Yang Y; Shao J; Zhao H; Wang G; Shen A Front Oncol; 2022; 12():1080985. PubMed ID: 36620594 [TBL] [Abstract][Full Text] [Related]
4. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma. Yu S; Tang L; Zhang Q; Li W; Yao S; Cai Y; Cheng H Hereditas; 2023 Jul; 160(1):31. PubMed ID: 37482612 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z Front Immunol; 2023; 14():1174762. PubMed ID: 37287976 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma. Chen Y Front Genet; 2022; 13():912037. PubMed ID: 35937995 [No Abstract] [Full Text] [Related]
7. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia. Li Y; Kan X Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332 [TBL] [Abstract][Full Text] [Related]
8. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer. Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma. Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226 [TBL] [Abstract][Full Text] [Related]
10. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170 [TBL] [Abstract][Full Text] [Related]
11. Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma. Guo T; Zhang J; Yuan Z; Tang H; Wang T; Wang X; Chen S J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556123 [TBL] [Abstract][Full Text] [Related]
12. Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma. Chen Y; Zou X; Ma M; Liu Y; Wang R; Dai Z; Tashiheng Y; Yan Y; Yu X; Wang X; Liu C; Lin X; Cheng H Curr Oncol; 2023 Jan; 30(2):1648-1662. PubMed ID: 36826087 [TBL] [Abstract][Full Text] [Related]
13. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma. Bian Z; Fan R; Xie L Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236 [TBL] [Abstract][Full Text] [Related]
14. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance. Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125 [TBL] [Abstract][Full Text] [Related]
15. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; Abrão FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
16. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma. Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D Front Immunol; 2023; 14():1181370. PubMed ID: 37600770 [TBL] [Abstract][Full Text] [Related]
17. Identification of cuproptosis-related genes for predicting the development of prostate cancer. Wang X; Chen X; Xu C; Zhou W; Wu D Open Med (Wars); 2023; 18(1):20230717. PubMed ID: 37711156 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity. Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W Front Genet; 2022; 13():939956. PubMed ID: 36105090 [No Abstract] [Full Text] [Related]
19. A novel cuproptosis-related signature predicts prognosis and immunotherapy efficacy in lung adenocarcinoma. Cui Y; Zhang LJ; Xu YJ; Liu MY Am J Transl Res; 2023; 15(6):3942-3959. PubMed ID: 37434829 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia. Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]